Recruiting
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
NCT06819228
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +17 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States